Data / Form D filings / AgeX Therapeutics, Inc.
AgeX Therapeutics, Inc.: Form D filings
AgeX Therapeutics, Inc., a biotechnology company in Alameda, CA, filed 5 Form D notices with the SEC between 2017 and 2019. The latest, on March 22, 2019, reports $4.5 million sold of a $5 million offering to 17 investors.
Find out what AgeX Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1010 ATLANTIC AVENUE, SUITE 102, Alameda, CA, 94501
- Phone
- (510) 521-3390
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2017
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1708599
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 22, 2019 | New notice | $5,000,000 | $4,500,000 | $500,000 | 17 | Mar 11, 2019 | sec.gov |
| Aug 27, 2018 | New notice | Indefinite | $200,000 | Indefinite | 1 | Aug 15, 2018 | sec.gov |
| Jun 21, 2018 | New notice | $5,000,000 | $5,000,000 | $0 | 1 | Jun 6, 2018 | sec.gov |
| Jan 31, 2018 | New notice | $1,000,000 | $462,500 | $537,500 | 20 | Jan 16, 2018 | sec.gov |
| Jul 10, 2017 | New notice | $10,000,000 | $8,850,000 | $1,150,000 | 18 | Jun 23, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Annalisa F. Jenkins | Director | |
| Michael D. West | Executive Officer, Director | |
| John F. Mauldin | Director | |
| Gregory D. Bailey | Director | |
| Not Applicable H. BioTime, Inc. | Promoter | |
| Michael H. Mulroy | Director | |
| Russell D. Skibsted | Executive Officer |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
- Tempest Therapeutics, Inc. $7.5 million · Oct 14, 2026
- Lionheart Health, Inc. $387,500 · Oct 7, 2026
- Rakuten Medical, Inc. $9 million · Oct 6, 2026
- Zonaliz, Inc. $2.5 million · Oct 5, 2026
- Altay Therapeutics, Inc. $15.7 million · Oct 2, 2026
- Sialia Therapeutics, Inc. $1.5 million · Sep 29, 2026
- Vetmab Biosciences, Inc. $11.4 million · Sep 29, 2026
Every Form D from the week of Mar 18, 2019 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AgeX Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.